Adrenal Insufficiency in Septic Shock

Clinics in Chest Medicine

Volumn 30, Issue 1, 2009, Pages 17-27

  Maxime, Virginie ^a   Lesur, Olivier ^b   Annane, Djillali ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Apelin; Corticosteroids; Corticotrophin test; Hydrocortisone; Hypothalamic pituitary adrenal axis; Vasopressin

Indexed keywords

APELIN; CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; ESTROGEN; ETOMIDATE; FLUCONAZOLE; FLUDROCORTISONE; GLUCOCORTICOID; GROWTH HORMONE; HORMONE; HYDROCORTISONE; KETOCONAZOLE; PHENYTOIN; PLACEBO; PREDNISOLONE; PROLACTIN; SOMATOMEDIN C; STEROID; TETRACOSACTIDE; VASOPRESSIN;

ADENOHYPOPHYSIS DISEASE; ADJUVANT THERAPY; ADRENAL INSUFFICIENCY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG MEGADOSE; ESTROGEN RELEASE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREGULATION; INFLAMMATION; KIDNEY DISEASE; LABORATORY TEST; LIVER FAILURE; LOW DRUG DOSE; MULTIPLE ORGAN FAILURE; MUSCLE WEAKNESS; MYOPATHY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROLACTIN RELEASE; RECOMMENDED DRUG DOSE; RESPIRATORY FAILURE; REVIEW; SEPSIS; SEPTIC SHOCK; THYROID DISEASE;

EID: 58849120086     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.10.003     Document Type: Review

References (103)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 7 (2001) 1303-1310
2. Schroeder S., Wichers M., Klingmuller D., et al. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Crit Care Med 29 2 (2001) 310-316
3. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358 9 (2008) 877-887
4. Parrillo J.E. Septic shock-vasopressin, norepinephrine, and urgency. N Engl J Med 358 9 (2008) 954-956
5. Bernard G.R., Wheeler A.P., Russell J.A., et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336 13 (1997) 912-928
6. Maxime V., Siami S., and Annane D. Metabolism modulators in sepsis: the abnormal pituitary response. Crit Care Med 35 9S (2007) S596-S601
7. Betancur C., Borrell J., and Guaza C. Cytokine regulation of corticosteroid receptors in the rat hippocampus: effects of interleukin-1, interleukin-6, tumor necrosis factor and lipopolysaccharide. Neuroendocrinology 62 1 (1995) 47-54
8. Imura H., and Fukata J. Endocrine-paracrine interaction in communication between the immune and endocrine systems. Activation of the hypothalamic-pituitary-adrenal axis in inflammation. Eur J Endocrinol 130 1 (1994) 32-37
9. Sternberg E.M. Neuroendocrine factors in susceptibility to inflammatory disease: focus on the hypothalamic-pituitary-adrenal axis. Horm Res 43 4 (1995) 159-161
10. Elenkov I.J., and Chrousos G.P. Stress system-organization, physiology and immunoregulation. Neuroimmunomodulation 13 5-6 (2006) 257-267
11. Pinsky M.R., Vincent J.L., Deviere J., et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103 2 (1993) 565-575
12. Thijs L.G., and Hack C.E. Time course of cytokine levels in sepsis. Intensive Care Med 21 Suppl 2 (1995) S258-S263
13. Loisa P., Rinne T., and Kaukinen S. Adrenocortical function and multiple organ failure in severe sepsis. Acta Anaesthesiol Scand 46 2 (2002) 145-151
14. Abraham E., and Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35 10 (2007) 2408-2416
15. Marik P.E., and Zaloga G.P. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 122 5 (2002) 1784-1796
16. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 7 (2002) 862-871
17. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 6 (1992) 1644-1655
18. Guillon G., Balestre M.N., Chouinard L., et al. Involvement of distinct G-proteins in the action of vasopressin on rat glomerulosa cells. Endocrinology 126 3 (1990) 1699-1708
19. Brown-Sequard C.E. Recherches expérimentales sur la physiologie et la pathologies des capsules surrenales. C R Hebd Séances Acad Sci (Paris) 43 (1856) 422-425
20. Collip J.B., Anderson E.M., and Thomson D.L. The adrenotropic hormone of the anterior pituitary lobe. Lancet 2 (1933) 347-348
21. Gallo-Payet N., and Guillon G. Regulation of adrenocortical function by vasopressin. Horm Metab Res 30 6-7 (1998) 360-367
22. Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321 8 (1989) 492-496
23. Papanek P.E., and Raff H. Chronic physiological increases in cortisol inhibit the vasopressin response to hypertonicity in conscious dogs. Am J Physiol 267 5 Pt 2 (1994) R1342-R1349
24. Holmes C.L., Patel B.M., Russel J.A., et al. Physiology of vasopressin relevant to management of septic shock. Chest 120 3 (2001) 989-1002
25. Mutlu G.M., and Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med 30 7 (2004) 1276-1291
26. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14 2 (1993) 76-122
27. Saavedra J.M., and Benicky J. Brain and peripheral angiotensin II play a major role in stress. Stress 10 2 (2007) 185-193
28. Aguilera G., Young W.S., Kiss A., et al. Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II. Neuroendocrinology 61 4 (1995) 437-444
29. Aguilera G., Kiss A., and Luo X. Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J Neuroendocrinol 7 10 (1995) 775-783
30. Castren E., and Saavedra J.M. Angiotensin II receptors in paraventricular nucleus, subfornical organ, and pituitary gland of hypophysectomized, adrenalectomized, and vasopressin-deficient rats. Proc Natl Acad Sci U S A 86 2 (1989) 725-729
31. Tatemoto K., Hosoya M., Habata, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251 2 (1998) 471-476
32. Renner U., Pagotto U., Arzt E., et al. Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review. Eur J Endocrinol 135 5 (1996) 515-532
33. Schwartz J., and Cherny R. Intercellular communication within the anterior pituitary influencing the secretion of hypophysial hormones. Endocr Rev 13 3 (1992) 453-475
34. Kleinz M.J., and Davenport A.P. Emerging roles of apelin in biology and medicine. Pharmacol Ther 107 2 (2005) 198-211
35. Reaux A., De Mota N., Skultetyova I., et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 77 4 (2001) 1085-1096
36. Reaux A., Gallatz K., Palkovits M., et al. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 113 3 (2002) 653-662
37. Reaux-Le Goazigo A., Alvear-Perez R., Zizzari P., et al. Cellular localization of apelin and its receptor in the anterior pituitary: evidence for a direct stimulatory action of apelin on ACTH release. Am J Physiol Endocrinol Metab 292 1 (2007) E7-E15
38. Gallo-Payet N, Roussy JF, Chagnon F, Roberge C, Lesur O. Hypothalamic/pituitary/adrenal axis and multiorgan defaillance system in critical illness; a special focus on arginine-vasopressin and apelin. J Organ Dysfunc 4, in press.
39. O'Dowd B.F., Heiber M., Chan A., et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136 1-2 (1993) 355-360
40. Cope C.L., and Black E. The production rate of cortisol in man. Br Med J 1 5078 (1958) 1020-1024
41. Kraft M., and Martin R.J. Chronobiology and chronotherapy in medicine. Dis Mon 41 8 (1995) 501-575
42. Daughaday W.H. Binding of corticosteroids by plasma proteins. I. Dialysis equilibrium and renal clearance studies. J Clin Invest 355 12 (1956) 1428-1433
43. Forest M.G., and Pugeat M. Binding proteins of steroid hormones vol. 149 (1986), Edition Libbey Eurotext, London
44. Siiteri P.K., Murai J.T., Hammond G.L., et al. The serum transport of steroid hormones. Recent Prog Horm Res 38 (1982) 457-510 [review]
45. Santini G., Patrignani P., Sciulli M.G., et al. The human pharmacology of monocyte cyclooxygenase 2 inhibition by cortisol and synthetic glucocorticoids. Clin Pharmacol Ther 70 5 (2001) 475-483
46. Tajima M., Maruyama S., Ichikawa M., et al. Mechanism of action of an anti-inflammatory steroid on changes in vascular permeability (II). Evaluation of its action as a phospholipase A2 inhibitor. Josai Shika Daigaku Kiyo 13 1 (1984) 60-67
47. Anderson R.L., Kraft P.E., Bensaude O., et al. Binding activity of glucocorticoid receptors after heat shock. Exp cell Res 197 1 (1991) 100-106
48. Hart L., Lim S., Adcock I., et al. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor κB. Am J Respir Crit Care Med 161 1 (2000) 224-231
49. Scheinman R.I., Cogswell P.C., Lofquist A.K., et al. Role of transcriptional activation of IkBα in mediation of immunosuppression by glucocorticoids. Science 270 5234 (1995) 283-286
50. Yende S, Angus DC, Bucala R. MIF and MODS. J Organ Dysf 4, in press.
51. Calandra T., Bernhagen J., Metz C.N., et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377 6544 (1995) 68-71
52. Melby J.C., and Spink W.W. Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection. J Clin Invest 37 12 (1958) 1791-1798
53. Koo D.J., Jackman D., Chaudry I.H., et al. Adrenal insufficiency during the late stage of polymicrobial sepsis. Crit Care Med 29 3 (2001) 618-622
54. McCann S.M., De Laurentiis A., and Rettori V. Chronology of advances in neuroendocrine immunomodulation. Ann N Y Acad Sci 1088 (2006) 1-11
55. Itoi K., Helmreich D.L., Lopez-Figueroa M.O., et al. Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J Neurosci 19 13 (1999) 5464-5472
56. Dünser M.W., Hasibeder W.R., Wenzel V., et al. Endocrinologic response to vasopressin infusion in advanced vasodilatory shock. Crit Care Med 32 6 (2004) 1266-1271
57. Lauzier F., Levy B., Lamarre P., et al. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 32 11 (2006) 1782-1789
58. Sharshar T., Blanchard A., Paillard M., et al. Circulating vasopressin levels in septic shock. Crit Care Med 31 6 (2003) 1752-1758
59. Hamrahian A.H., Oseni T.S., and Arafah B.M. Measurements of serum free cortisol in critically ill patients. N Engl J Med 350 16 (2004) 1629-1638
60. Cooper M.S., Bujalska I., Rabbitt E., et al. Modulation of 11β-hydroxysteroid deshydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res 16 6 (2001) 1037-1044
61. Venkatesh B., Cohen J., Hickman I., et al. Evidence of altered cortisol metabolism in critically ill patients: a prospective study. Intensive Care Med 33 10 (2007) 1746-1753
62. Marik P.E. The diagnosis of adrenal insufficiency in the critically ill patient: Does it really matter?. Crit Care 10 5 (2006) 176
63. Annane D. Time for consensus definition of corticosteroid insufficiency in critically ill patients. Crit Care Med 31 6 (2003) 1868-1869
64. Annane D., Sébille V., Troché G., et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin. JAMA 283 8 (2000) 1038-1045
65. Prigent H., Maxime V., and Annane D. Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care 8 4 (2004) 243-252
66. Waterhouse R. Case of suprarenal apoplexy. Lancet 1 (1911) 577
67. Case records of the Massachusetts Heneral Hospital (case 15-2001). N Engl J Med 344 (2001) 1536-1542
68. Cooper M.S., and Stewart P.M. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348 8 (2003) 727-734
69. Sharshar T., Gray F., Lorin de la Grandmaison G., et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inductible nitric oxide synthase after death from septic shock. Lancet 362 9398 (2003) 1799-1805
70. Wagner R.L., White P.F., Kan P.B., et al. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 310 22 (1984) 1415-1421
71. Mohammad Z., Afessa B., and Finkielman J.D. The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care 10 4 (2006) R105
72. Albert S.G., DeLeon M.J., and Silverberg A.B. Possible association between high-dose fluconazole and adrenal insufficiency in critical ill patients. Crit Care Med 29 3 (2001) 668-670
73. Vinclair M., Broux C., Faure P., et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med 34 4 (2008) 714-719
74. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 358 2 (2008) 111-124
75. Pascualy M., Petrie E.C., Brodkin K., et al. Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in Alzheimer's disease. Biol Psychiatry 48 3 (2000) 247-254
76. Cho Y.M., Kim S.Y., Cho B.Y., et al. Dissociation between plasma adrenocorticotropin and serum cortisol level during the early post operative period after gastrectomy. Horm Res 53 5 (2000) 246-250
77. Droste S.K., Gesing A., Ulbricht S., et al. Effects of long term voluntary exercise on the mouse hypothalamic-pituitary adrenal axis. Endocrinology 144 7 (2003) 3012-3023
78. Droste S.K., Chandramohan Y., Hill L.E., et al. Voluntary exercise impacts on the rat hypothalamic-pituitary adrenal axis mainly at the adrenal level. Neuroendocrinology 86 1 (2007) 26-37
79. Bornstein S.R., Engeland W.C., Ehrhart-Bornstein M., et al. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab 19 5 (2008) 175-180
80. Dorin R.I., Qualls C.R., and Crapo L.M. Diagnosis of adrenal insufficiency. Ann Intern Med 139 3 (2003) 194-204
81. Marik P.E., Pastores S.M., Annane D., et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critical ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 36 6 (2008) 1937-1949
82. Arafah B.M., Nishiyama F.J., Tlaygeh H., et al. Measurement of salivary cortisol concentration in the assessment adrenal function in critical ill subjects: a surrogate marker of the circulating free cortisol. J Clin Endocrinol Metab 92 28 (2007) 2965-2971
83. Sederberg-Olsen P., Binder C., and Kehlet H. Urinary excretion of free cortisol in impaired renal function. Acta Endocrinol 78 1 (1975) 86-90
84. Annane D., Maxime V., Ibrahim F., et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 174 12 (2006) 1319-1326 [Epub 2006 Sep 14]
85. Slotman GJ, Fisher CJ, Bone RC, et al. Detrimental effects of high dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med;21(2):191-5.
86. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. Br Med J 329 7464 (2004) 480
87. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of sever sepsis and septic shock: 2008. Crit Care Med 36 1 (2008) 296-327
88. De Jonghe B., Sharshar T., Lefaucheur J.P., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288 22 (2002) 2859-2867
89. Herridge M.S., Cheung A.M., Tansey C.M., et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348 8 (2003) 683-693
90. Van den Berghe G., Schoonheydt K., Becx P., et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 8 (2005) 1348-1353
91. Hermans G., Wilmer A., Meersseman W., et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175 5 (2007) 480-489
92. Bollaert P.E., Charpentier C., Levy B., et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26 4 (1998) 645-650
93. Briegel J., Forst H., Haller M., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single center study. Crit Care Med 27 4 (1999) 723-732
94. Chawla K., Kupfer Y., and Tessler S. Hydrocortisone reverses refractory septic shock. Crit Care Med 27 (1999) A33
95. Yildiz O., Doganay M., Aygen B., et al. Physiological-dose steroid therapy in sepsis. Crit Care 6 3 (2002) 251-259
96. Keh D., Boehnke T., Weber-Cartens S., et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167 4 (2003) 512-520
97. Confalonieri M., Urbino R., Potena A., et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171 3 (2005) 242-248
98. Oppert M., Schindler R., Husung C., et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 33 11 (2005) 2457-2464
99. Tandan S.M., Guleria R., and Gupta N. Low dose steroids and adrenocortical insufficiency in septic shock: a double-blind randomised controlled trial from India. Am J Respir Crit Care Med (2005) A24
100. Rinaldi S., Adembri C., Grechi S., et al. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med 34 9 (2006) 2334-2339
101. Cicarelli D.D., Vieira J.E., and Besenor F.E. Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J 125 4 (2007) 237-241
102. Mikami K., Suzuki M., Kitagawa H., et al. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung 185 5 (2007) 249-255
103. Huh J.W., Lim C.M., Koh Y., et al. Effect of low doses of hydrocortisone in patient with septic shock and relative adrenal insufficiency: 3 days versus 7 days treatment. Crit Care Med 34 (2007) A101